Objective-To determine the progression rates to AIDS in women in Dublin. Subjects and methods-109 HIV-1 sero-positive women who presented to the Department of Genitourinary Medicine, St. James's Hospital, Dublin, were included in a retrospective analysis. Of these 101 (93%) were intravenous drug users (IVDUs), 7 were heterosexual partners of IVDUs and one had a hetero-sexual partner of no known risk group. Forty-four women (40%) had had 57 children since the time of their first known HIV seropositive test. Progression rates from CDC Stage 11/111 co AIDS are computed. Progression curves are generated according to the Kaplan-Meier method using the Statistical Analysis Software (SAS). Results-The estimated cumulative progression rate at 5 years was 24% (SE 6.6%). 17 out of 109 (15.6%) developed AIDS. The mean follow up lime was 2.8 years (SE 0.2). The prevalence of oesophageal candidiasis taking development of AIDS as the point in time was 9 out of 17 (53%), of Mycobacterium hominis infection (TB) 5 (29%) and of Pneunmcystis carcinii pneumonia (PCP) 2 (12%). There was no statistical difference in progression rates to AIDS between those women who had children after becoming infected versus those who had none. Conclusions-Progression rates to AIDS in Irish women is higher than reported in other studies of homosexual/bisexual men, but is similar to rates estimated for both male and female IVDUs. Oesophageal candidiasis is the commonest presenting AIDS diagnosis followed by TB, while PCP is rare, contrary to the findings of similar studies in the USA.
Introduction
The acquired immunodeficiency syndrome (AIDS) epidemic has grown slowly in Ireland. The first reported case was in a homosexual man in 1982 and there were a total of 258 cases in the Republic by the end of 1991.
1 However, by November 1991, 1146 individuals in Ireland had tested positive for die HIV antibody, 150 (13.1%) of whom were female. Most of these women are intravenous drug users (IVDU). The proportion of AIDS cases arising from the IVDU risk group has risen steadily from 30% at the end of 1987 to 37% at die end of 1991 and with it the proportion of AIDS cases among women. A similar increase in die incidence of AIDS in women has been reported in other countries, in particular the USA. [2] [3] Therefore it is of increasing importance to examine the natural history of HIV infection in women. Here we outline the details of such a study. The majority of Irish HIV cases are centred in the Dublin area and 109 HIV positive Irish women have attended the Genito urinary clinic in St. James's Hospital, Dublin. A retrospective analysis of HIV positive female admissions to the clinic for the period January 1987 to January 1991 was conducted.
Progression rates to any Center for Disease Control (CDC) group IV disease and to AIDS for these women are presented. Possible effect of pregnancy during the course of HIV infection on progression rates is explored. Progression rates for women who do not have babies during the course of their HIV infection are compared with those for women who do. We also compare our progression rates with those of homosexual cohort studies and with other cohort studies of IVDU's compiled from the literature.
Patients and methods
A total of 109 women who presented at the Dublin sexually transmitted disease clinic between January 1987 and January 1990 were anu-HIV-1 seropositive. They were followed to 1 February 1991. The dates of their first positive HIV test ranged from 15 January, 1983 to 30 September, 1990, the median date being 15 June, 1987. The CDC classification of 1987 4 for the manifestation of HIV infection was used to classify patients. The major transmission category was TV drug usage. Of the 109 women, 101 (93%) were IV drug users, seven were heterosexual partners of IV drug users (6.4%) and one had a heterosexual partner of no known risk group. Six of the 101 IV drug users were prostitutes. At the time of study, 74 of the 101 (73%) were ex IVDUs of whom 54 (53%) were on methadone, Twenty-seven were current users (27%), 16 of whom were on methadone. Seventeen patients received antiretroviral therapy, 14 after an AIDS diagnosis. CD4 ceil counts were not available on a routine basis so PCP prophylaxis was not initiated unless die patient had reached CDC Stage IV diagnosis.
Forty-four (40%) of the women had had children, since the time of their first known HIV positive test. A total of 57 children were born; nine women had two children, two had three and the remaining 33 had a single pregnancy since seroconversion.
Progression races from CDC stages II and III to AIDS were computed. All progression curves were generated according to the Kaplan-Meier method using the Statistical Analysis Software (SAS). For each patient the date of first known HIV-seropositive result was the starting point on the follow-up scale. The exception to this were seven patients for whom an HIVseronegative date was available. For these seven, the starting point was taken as the date midway between the last known negative and first known positive tests for anti-HIV. In computing progression rates to AIDS ail 109 patients were included in the risk set. The number of days of follow-up was taken to the date at which the patient developed an AIDS illness or the date of last visit at the clinic at which the patient was asymtomatic, before 1 February 1991.
Results
The average age at entry to the Study was 25.6 years with a standard error of 0. The progression rates to AIDS and the associated standard errors, together with the sample sizes on which the estimates are based are shown in table 2. The progression rate to AIDS at 4 years is 12% and at 5 years is 24% (fig 1) .
All the women were of child-bearing age and 44 (40%) of them had children after becoming infected. Eight (18%) of women who had babies progressed to AIDS and the rate was 14% for women who did not have babies. The Kaplan-Meier progression curves to AIDS for the two groups were nor significantly different. Likewise there was no statistical difference in progression between current IVDUs and ex-IVDUs (Log Rank Test). Moreover, age was not a statistically confounding factor in either of these analyses.
Discussion
The pattern of AIDS presentation as seen in table 1 is different from that reported in the USA, where the incidence of PCP among infected women is higher and the incidence of oesophageal candidiasis is rare. Guinan et al 5 in a study of 1819 women with AIDS in the USA reported a 66% incidence of PCP, similar to males in the USA. In a study at The New York Hospital 6 of women with AIDS, 57.1% had PCP as their first opportunistic infection versus 10.7% with oesophageal candidiasis. By contrast 35.3% had oesophageal candidiasis in this study. However Carpenter et al 7 8 compiled progression rates to AIDS of six independent cohorts of homosexual and bisexual men. In each study the dace of seroconversion of the subjects was either known or estimated. The estimated cumulative rates at five years ranged from 11 % to 23% with a median of 14%. The corresponding estimate in this study is 24% (SE 6.6%), the highest in comparison. There are two possible explanations for this. Some women may have been HIV positive for a long time before coming to the clinic. The study at The New York Hospital also found that women tend Co seek treatment late in their clinical course. Thus they have been infected for longer than their follow-up in this study, and as it is well known chat the risk of AIDS for HIV infected persons increases over time, it is possible we have overestimated the progression rates. An alternative explanation is that most of the women are IVDUs and progression rates among IVDUs are higher than in other risk groups because of an already weakened immune system. Table 3 shows cumulative progression rates from four studies of IVDU's, 9-12 male and female, compiled from the literature. The estimated cumulative races at five years ranged from 23% to 48% with a median of 35%. The corresponding estimate in this study is 24% showing good agreement. Undoubtedly, progression rates for IVDUs seem to be consistently higher than in die homosexual/bisexual group, suggesting that IVDUs have a poorer prognosis. Currently there is no evidence to suggest mat progression races differ between male and female IVDUs. There is, however, a lot of variability across studies perhaps because of unknown seroconversion dates.
Selwyn et al 13 found no adverse effect of pregnancy or HIV progression in a prospective study of 24 seropositive IVDUs. Our data also support this study. This contrasts with earlier studies of HIV, in which HIV disease was found to progress dramatically during or following pregnancy. Lindgren et al 14 suggest that progression was related to the delivery of an affected baby. Comprehensive data on the HIV status of the children born in our study is incomplete and therefore we cannot comment on this issue at this time.
An increase in AIDS among women from heterosexual partners is a good marker for future trends in the heterosexual population, and is of particular concern. However, the extent to which HIV transmission occurs from the IVDU population to the general heterosexual population is not known. Six percent of women in this study were infected in this manner. Nine percent of AIDS cases in Ireland to December 1991 had occurred in heterosexuals and heterosexuals with no known risk accounted for 11% of HIV seropositive cases. Two studies, in the USA 15 and Italy 16 have compared progression rates for women in the IVDU and heterosexual risk groups. The US study concluded that women in the IVDU risk group progress more rapidly than women without IVDU history, while the Italian study found the reverse was true, Owing to the small numbers of heterosexuals in this study, it was not possible to compare these groups. Further studies to clarify this important issue are urgently required.
